Mitoxantrone-Melphalan Conditioning Regimen for Autologous Stem Cell Transplantation in Relapsed/Refractory Lymphoma

Turkish Journal of Medical Sciences - Turkey
doi 10.3906/sag-1809-36
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

The Scientific and Technological Research Council of Turkey

Related search

High-Dose BCNU/Melphalan Conditioning Regimen Before Autologous Stem Cell Transplantation in Newly Diagnosed Multiple Myeloma

Bone Marrow Transplantation
TransplantationHematology
2017English

Outcomes of Autologous Stem Cell Transplantation (ASCT) in Patients With Relapsed/Refractory HIV-associated Lymphoma

Bone Marrow Transplantation
TransplantationHematology
2016English

Phase II Trial of High-Dose Gemcitabine/Busulfan/Melphalan With Autologous Stem-Cell Transplantation for Primary Refractory or Poor-Risk Relapsed Hodgkin's Lymphoma

Biology of Blood and Marrow Transplantation
TransplantationHematology
2018English

Autologous Stem Cell Transplantation for Refractory or Poor-Risk Relapsed Hodgkin's Lymphoma: Effect of the Specific High-Dose Chemotherapy Regimen on Outcome

Biology of Blood and Marrow Transplantation
TransplantationHematology
2013English

Prognostic Factors and Long-Term Outcome of Autologous Haematopoietic Stem Cell Transplantation Following a Uniform-Modified BEAM-conditioning Regimen for Patients With Refractory or Relapsed Hodgkin Lymphoma: A Single-Center Experience

Medical Oncology
MedicineCancer ResearchOncologyHematology
2013English

A Comparison Between BEAM and BEM Conditioning Regimens for Autologous Hematopoietic Stem Cell Transplantation in Relapsed Lymphoma: A Retrospective Analysis

Biology of Blood and Marrow Transplantation
TransplantationHematology
2019English

Brentuximab Vedotin Salvage Followed by Consolidation Post Autologous Hematopoietic Stem Cell Transplantation in High Risk Relapsed Refractory Hodgkin Lymphoma

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Autologous Stem Cell Transplantation for Hodgkin's Disease: Busulfan, Melphalan and Thiotepa Compared to a Radiation-Based Regimen

Bone Marrow Transplantation
TransplantationHematology
2003English

Haploidentical Hematopoietic Stem Cell Transplantation Compared With Hla-Matched Stem Cell Transplantation for Refractory or Relapsed Aggressive Non-Hodgkin Lymphoma

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy